L, W., L, P., A, M., AS, N., K, W., M, K., . . . M, S. (2026). TP53 deficiency in AML induces resistance to T-cell engagers through an immunosuppressive secretome. Leukemia. https://doi.org/10.1038/s41375-026-02991-6
Chicago Style (17th ed.) CitationL, Winter, et al. "TP53 Deficiency in AML Induces Resistance to T-cell Engagers Through an Immunosuppressive Secretome." Leukemia 2026. https://doi.org/10.1038/s41375-026-02991-6.
MLA (9th ed.) CitationL, Winter, et al. "TP53 Deficiency in AML Induces Resistance to T-cell Engagers Through an Immunosuppressive Secretome." Leukemia, 2026, https://doi.org/10.1038/s41375-026-02991-6.
Warning: These citations may not always be 100% accurate.